JPRN-UMIN000011277已完成未知
he efficacy of alogliptin to gastrin and glycemic control in patients with type 2 diabetes under treatment with gastric secretion inhibitor and gastroprotective agents - The efficacy of alogliptin to gastrin and glycemic control
ational Hospital Organization National Kochi Hospital,0 个研究点目标入组 50 人开始时间: 2013年7月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •diabetic ketosis severe infection before and after operation patients with severe trauma past history of allergy against alogliptin
研究者
相似试验
尚未招募
2 期
The effect of Alogliptin in the prevention of Type 1 Diabetes MellitusC18.452.394.750Type 1 Diabetes mellitusRBR-723bk5pniversidade Federal do Ceará
已完成
不适用
The effect of sitagliptin or alogliptin on blood glucose levels and vascular endothelial function in type2 diabetestype 2 diabetes mellitusJPRN-UMIN000011117Fukuoka Tokushukai Hospital20
尚未招募
不适用
The effect of omarigliptin on glucose excursion using continuous glucose monitoring in the elderly patients with type2 diabetestype 2 diabetesJPRN-UMIN000021815Department of Endoclinology, Gifu University Graduate School of Medicine10
已完成
4 期
Effects of sitagliptin and vildagliptin on glucose fluctuations in patients with type 2 diabetes -prospective open-label controlled studytype 2 diabetes mellitusJPRN-UMIN000005627Department of Medicine II, Hokkaido University Hospital40
已完成
不适用
Study on the effects of sitagliptin on glycemic control in newly treated or uncontrolled patients with type 2 diabetes mellitusType 2 diabetes mellitusJPRN-UMIN000019154Kanto Antidiabetics Study Group1,400